Expanded Access to ABBV-CLS-484

Sponsor: Calico Life Sciences LLC

Expanded Access
Sponsor score: 60
Inactive

ClinicalTrials ID:NCT06188975

Patient View

This expanded access program provides ABBV-CLS-484 to eligible participants before regulatory approval. Eligibility is determined by a medical doctor based on individual medical history and program criteria. The intervention involves administering the investigational drug ABBV-CLS-484. Availability is subject to territory eligibility, ensuring access where possible.

Patient Parameters

Program Overview

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-CLS-484 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

Get This Program In Your Inbox

You can sign up and apply your patients for this program.